FIELD: medicine, pharmaceutics, ophthalmology.
SUBSTANCE: the present innovation deals with treating keratitis and conjunctivitis. The suggested gel contains metronidasol as an active substance, buffer solution consisting of sodium tetraborate, and gel foundation that consists of styrene copolymer with maleic anhydride and purified water at the following ratio of components, weight%: metronidasol 0.5; sodium tetraborate 0.018; styrene copolymer with maleic anhydride 1.0; purified water up to 100.0. The suggested gel is of prolonged antiviral, antiphlogistic and antibacterial actions, it is hygienic and comfortable in application.
EFFECT: higher efficiency of therapy.
3 dwg, 6 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASE USING METRONIDAZOL AND OXYMETHYLURACIL | 2003 |
|
RU2241455C1 |
| ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
| MEDICINAL PREPARATION FOR TREATING INFLAMMATORY DISEASES OF MOUTH CAVITY | 2003 |
|
RU2226383C1 |
| AGENT FOR ACCELERATING WOUND HEALING | 2003 |
|
RU2239415C1 |
| OINTMENT WITH METRONIDAZOLE, BEE MOTH LARVAE EXTRACT AND ANAESTHESINE FOR INTEGRATED TREATMENT OF INFLAMMATORY PERIODONTAL DISEASES | 2014 |
|
RU2564944C1 |
| OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2456978C1 |
| OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS | 2011 |
|
RU2438650C1 |
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| AGENT FOR TREATMENT OF PATIENT WITH HERPETIC KERATITIS | 1996 |
|
RU2135187C1 |
| ANTIVIRUS AGENT WITH HUMAN LEUKOCYTIC HUMAN INTERFERON BASED ON CHITOSAN SUCCINATE | 2009 |
|
RU2404796C1 |
